Pembrolizumab
Merck
['rcc,(-irccs),(-srcc),(-urcc)']
nice summary! #kyn564 is the largest trial to date &amp; only one showing a trend in os even after 30 mths (very short f/u for adjuvant rcc) even when taking t3 alone (exclude t4/n1/m1ned) : hr 0.68! #esmo22 
Cancer researcher; Director of GU Cancers @DanaFarber; Prof of Medicine @HarvardMed; ? lover; ??@PanMass
Views are mine.